TTop stories Read More Eli Lilly (LLY) Q2 2025 earnings reportAugust 7, 2025 The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept.…
TTop stories Read More Eli Lilly obesity pill orforglipron led to 12% weight lossAugust 7, 2025 A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
TTop stories Read More Trump says pharma tariffs could eventually reach up to 250%August 5, 2025 U.S. President Donald Trump talks to members of the press at Lehigh Valley International Airport in Allentown, Pennsylvania,…
TTop stories Read More Pfizer (PFE) Q2 2025 earnings reportAugust 5, 2025 Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press |…
HHeadlines Read More Trump asks drugmakers to cut U.S. prices within 60 daysJuly 31, 2025 U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz,…
HHeadlines Read More Covid vaccine makers Moderna BioNTech stocks, mRNA strategies divergeJuly 31, 2025 A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March…
TTop stories Read More Merck (MRK) earnings report Q2 2025July 29, 2025 Merck & Co. signage on the floor of the New York Stock Exchange (NYSE) in New York, US,…
TTop stories Read More UnitedHealth Group (UNH) earnings report Q2 2025July 29, 2025 UnitedHealth Group on Tuesday issued a 2025 outlook that fell short of Wall Street’s expectations, as the company’s…
TTop stories Read More UnitedHealth facing DOJ investigation over Medicare billingJuly 24, 2025 The UnitedHealth logo on a laptop arranged in New York, US, on Friday, July 7, 2023. Gabby Jones…
TTop stories Read More Sarepta to pause gene therapy Elevidys shipments in U.S.July 22, 2025 Thomas Fuller | SOPA Images | Lightrocket | Getty Images Sarepta Therapeutics said on Monday it will pause…
TTop stories Read More Sarepta stock falls on FDA gene therapy Elevidys commentJuly 18, 2025 Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New…
TTop stories Read More Tylenol maker Kenvue fires CEO Thibaut MongonJuly 14, 2025 Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson consumer-health business, speaks during an interview with CNBC…